Is percutaneous cholecystostomy bridge to cholecystectomy or definite therapy in high-risk patients with severe acute calculous cholecystitis?

harman, ali; Karagülle, Erdal; Moray, Gökhan; avcı, tevfik; Aydin, Huseyin Onur; Yabanoğlu, Hakan

doi:10.5455/annalsmedres.2020.08.819

Is percutaneous cholecystostomy bridge to cholecystectomy or definite therapy in high-risk patients with severe acute calculous cholecystitis?

Tevfik AVCI, (Başkent Üniversitesi, Tıp Fakültesi, Genel Cerrahi Anabilim Dalı, Ankara, Türkiye)

Hakan YABANOĞLU, (Başkent Üniversitesi, Tıp Fakültesi, Adana Eğitim ve Araştırma Merkezi, Genel Cerrahi Anabilim Dalı, Adana, Türkiye)

Hüseyin AYDIN, (Başkent Üniversitesi, Tıp Fakültesi, Adana Eğitim ve Araştırma Merkezi, Genel Cerrahi Anabilim Dalı, Adana, Türkiye)

Erdal KARAGÜLLE, (Başkent Üniversitesi, Tıp Fakültesi, Genel Cerrahi Anabilim Dalı, Konya Eğitim ve Araştırma Merkezi, Konya, Türkiye)

Gökhan MORAY, (Başkent Üniversitesi, Tıp Fakültesi, Genel Cerrahi Anabilim Dalı, Ankara, Türkiye)

Ali HARMAN (Başkent Üniversitesi, Tıp Fakültesi, Genel Radyoloji Anabilim Dalı, Ankara, Türkiye)

Annals of Medical Research

0 0

Yıl: 2021 Cilt: 28 Sayı: 1 Sayfa Aralığı: 113 - 119 Metin Dili: İngilizce DOI: 10.5455/annalsmedres.2020.08.819 İndeks Tarihi: 28-06-2021

Is percutaneous cholecystostomy bridge to cholecystectomy or definite therapy in high-risk patients with severe acute calculous cholecystitis?

Öz:

Aim: The medical records of 68 patients diagnosed with severe ACC and treated with PC at Başkent University Faculty of Medicine, General Surgery Clinic between January 2011 and January 2018 were retrospectively analyzed.Results: Among patients who underwent PC for severe ACC at our clinic, 39 (57.4%) were male. Their mean age was 71.7 (28-94) years. All patients had pain; 13 (19.1%) patients had nausea-vomiting; 8 (11.8%) had had fever. The mean time from symptom onset to hospital admission was 6.2 (1-30) days; the mean time from admission to PC placement was 2.1 (1-9) days. Twelve (17.6%) patients had minor complications due to cholecystostomy catheter. Twenty seven (39.7%) patients underwent cholecystectomy with a mean of 83.1 (20-705) days after cholecystostomy placement. Seventeen of these patients underwent laparoscopic surgery and 3 of them converted to open surgery. In 5 of 41 patients who did not undergo cholecystectomy, AC recurrence developed (12.2%) and PC was inserted again. Five (7.4%) patients died.Conclusion: Percutaneous cholecystostomy catheter is an effective treatment to control inflammation until cholecystectomy among high-risk patients diagnosed with severe cholecystitis and may be a definitive therapy for patients unable to undergo surgery.

Anahtar Kelime:

Belge Türü: Makale Makale Türü: Araştırma Makalesi Erişim Türü: Erişime Açık

1. Everhart JE, Khare M, Hill M, et al. Prevalence and ethnic differences in gallbladder disease in the United States. Gastroenterology 1999;117:632–9.
2. Gerard J, Luu MB, Poirier J, et al. Acute cholecystitis: comparing clinical outcomes with TG13 severity and intended laparoscopic versus open cholecystectomy in difficult operative cases. Surg Endosc 2018;32:3943- 8.
3. Charrier T, Kepenekian V, Muller A, et al. Management after Percutaneous Cholecystostomy: What Should We do with the Catheter? Surg Laparosc Endosc Percutaneous Tech 2018;28:256-60.
4. Hirota M, Takada T, Kawarada Y, et al. Diagnostic criteria and severity assessment of acute cholecystitis: Tokyo Guidelines. J Hepatobiliary Pancreat Surg 2007;14:78–82.
5. Yokoe M, Takada T, Strasberg SM, et al. TG13 diagnostic criteria and severity grading of acute cholecystitis (with videos). J Hepatobiliary Pancreat Sci 2013;20:35–46.
6. Yamashita Y, Takada T, Strasberg SM, et al. TG13 surgical management of acute cholecystitis. J Hepatobiliary Pancreat Sci 2013;20:89–96.
7. Miura F, Takada T, Strasberg SM, et al. TG13 flowchart for the management of acute cholangitis and cholecystitis. J Hepatobiliary Pancreat Sci 2013;20:47–54.
8. Atar E, Bachar GN, Berlin S, et al. Percutaneous cholecystostomy in critically ill patients with acute cholecystitis: Complications and late outcome. Clin Radiol 2014;69:e247–e252.
9. Nasim S, Khan S, Alvi R, et al. Emerging indications for percutaneous cholecystostomy for the management of acute cholecystitis - A retrospective review. Int J Surg 2011;9:456–9.
10. Cherng N, Witkowski ET, Sneider EB, et al. Use of cholecystostomy tubes in the management of patients with primary diagnosis of acute cholecystitis. J Am Coll Surg 2012;214:196–201.
11. Ozyer U. Long-term results of percutaneous cholecystostomy for definitive treatment of acute acalculous cholecystitis: A 10-year single-center experience. Acta Gastroenterol Belg 2018;81:393-7.
12. Kirkegård J, Horn T, Christensen SD, et al. Percutaneous cholecystostomy is an effective definitive treatment option for acute acalculous cholecystitis. Scand J Surg 2015;104:238-43.
13. Pang KW, Tan CHN, Loh S, et al. Outcomes of Percutaneous Cholecystostomy for Acute Cholecystitis. World J Surg 2016;40:2735-44.
14. Kortram K, van Ramshorst B, Bollen TL, et al. Acute cholecystitis in high risk surgical patients: Percutaneous cholecystostomy versus laparoscopic cholecystectomy (CHOCOLATE trial): Study protocol for a randomized controlled trial. Trials 2012;13-7.
15. Winbladh A, Gullstrand P, Svanvik J, et al. Systematic review of cholecystostomy as a treatment option in acute cholecystitis. HPB 2009;11:183-93.
16. Campanile FC, Pisano M, Coccolini F, et al. Acute cholecystitis: WSES position statement. World J Emerg Surg 2014;9:1-6.
17. Işık A, Fırat D, Korkmaz S, et al. Atipik Prezente Kist Hidatik: Pankreas Başında Kitle. Sak Med J 2018;8:149–52.
18. Işık A, Sayar İ, Gülhan B, et al. Fascioliasis: cholelithiasis mimicking a rare case. J Kartal Train Res Hosp 2016;27:145–6.
19. Stanek A, Dohan A, Barkun J, et al. Percutaneous cholecystostomy: A simple bridge to surgery or an alternative option for the management of acute cholecystitis? Am J Surg 2018; 216:595-603.
20. Joseph T, Unver K, Hwang GL, et al. Percutaneous cholecystostomy for acute cholecystitis: Ten-year experience. J Vasc Interv Radiol 2012;23:83-8.
21. Bundy J, Srinivasa RN, Gemmete JJ, et al. Percutaneous Cholecystostomy: Long-Term Outcomes in 324 Patients. Cardiovasc Intervent Radiol 2018;41:928- 34.
22. Sosna J, Copel L, Kane RA, et al. Ultrasoundguided percutaneous cholecystostomy: update on technique and clinical applications. Surg Technol Int 2003;11:135-9.
23. Akhan O, Akinci D, Özmen MN. Percutaneous cholecystostomy. Eur J Radiol 2002;43:229-36.
24. Hersey N, Goode SD, Peck RJ, et al. Stenting of the Cystic Duct in Benign Disease: A Definitive Treatment for the Elderly and Unwell. Cardiovasc Intervent Radiol 2015;38:964-70.
25. Jang WS, Lim JU, Joo KR, et al. Outcome of conservative percutaneous cholecystostomy in highrisk patients with acute cholecystitis and risk factors leading to surgery. Surg Endosc 2015;29:2359-64.
26. Sanjay P, Mittapalli D, Marioud A, et al. Clinical outcomes of a percutaneous cholecystostomy for acute cholecystitis: A multicentre analysis. HPB 2013;15:511-6.
27. De Mestral C, Gomez D, Haas B, et al. Cholecystostomy: A bridge to hospital discharge but not delayed cholecystectomy. J Trauma Acute Care Surg 2013;74:175-80.
28. Horn T, Christensen SD, Kirkegård J, et al. Percutaneous cholecystostomy is an effective treatment option for acute calculous cholecystitis: A 10-year experience. HPB 2015;17:326-31.
29. Molavi I, Schellenberg A, Christian F. Clinical and operative outcomes of patients with acute cholecystitis who are treated initially with imageguided cholecystostomy. Can J Surg 2018;61:195-9.
30. Mizrahi I, Mazeh H, Yuval JB, et al. Perioperative outcomes of delayed laparoscopic cholecystectomy for acute calculous cholecystitis with and without percutaneous cholecystostomy. Surgery (United States) 2015; 158:728-35.

APA	avcı t, Yabanoğlu H, Aydin H, Karagülle E, Moray G, harman a (2021). Is percutaneous cholecystostomy bridge to cholecystectomy or definite therapy in high-risk patients with severe acute calculous cholecystitis?. , 113 - 119. 10.5455/annalsmedres.2020.08.819
Chicago	avcı tevfik,Yabanoğlu Hakan,Aydin Huseyin Onur,Karagülle Erdal,Moray Gökhan,harman ali Is percutaneous cholecystostomy bridge to cholecystectomy or definite therapy in high-risk patients with severe acute calculous cholecystitis?. (2021): 113 - 119. 10.5455/annalsmedres.2020.08.819
MLA	avcı tevfik,Yabanoğlu Hakan,Aydin Huseyin Onur,Karagülle Erdal,Moray Gökhan,harman ali Is percutaneous cholecystostomy bridge to cholecystectomy or definite therapy in high-risk patients with severe acute calculous cholecystitis?. , 2021, ss.113 - 119. 10.5455/annalsmedres.2020.08.819
AMA	avcı t,Yabanoğlu H,Aydin H,Karagülle E,Moray G,harman a Is percutaneous cholecystostomy bridge to cholecystectomy or definite therapy in high-risk patients with severe acute calculous cholecystitis?. . 2021; 113 - 119. 10.5455/annalsmedres.2020.08.819
Vancouver	avcı t,Yabanoğlu H,Aydin H,Karagülle E,Moray G,harman a Is percutaneous cholecystostomy bridge to cholecystectomy or definite therapy in high-risk patients with severe acute calculous cholecystitis?. . 2021; 113 - 119. 10.5455/annalsmedres.2020.08.819
IEEE	avcı t,Yabanoğlu H,Aydin H,Karagülle E,Moray G,harman a "Is percutaneous cholecystostomy bridge to cholecystectomy or definite therapy in high-risk patients with severe acute calculous cholecystitis?." , ss.113 - 119, 2021. 10.5455/annalsmedres.2020.08.819
ISNAD	avcı, tevfik vd. "Is percutaneous cholecystostomy bridge to cholecystectomy or definite therapy in high-risk patients with severe acute calculous cholecystitis?". (2021), 113-119. https://doi.org/10.5455/annalsmedres.2020.08.819

APA	avcı t, Yabanoğlu H, Aydin H, Karagülle E, Moray G, harman a (2021). Is percutaneous cholecystostomy bridge to cholecystectomy or definite therapy in high-risk patients with severe acute calculous cholecystitis?. Annals of Medical Research, 28(1), 113 - 119. 10.5455/annalsmedres.2020.08.819
Chicago	avcı tevfik,Yabanoğlu Hakan,Aydin Huseyin Onur,Karagülle Erdal,Moray Gökhan,harman ali Is percutaneous cholecystostomy bridge to cholecystectomy or definite therapy in high-risk patients with severe acute calculous cholecystitis?. Annals of Medical Research 28, no.1 (2021): 113 - 119. 10.5455/annalsmedres.2020.08.819
MLA	avcı tevfik,Yabanoğlu Hakan,Aydin Huseyin Onur,Karagülle Erdal,Moray Gökhan,harman ali Is percutaneous cholecystostomy bridge to cholecystectomy or definite therapy in high-risk patients with severe acute calculous cholecystitis?. Annals of Medical Research, vol.28, no.1, 2021, ss.113 - 119. 10.5455/annalsmedres.2020.08.819
AMA	avcı t,Yabanoğlu H,Aydin H,Karagülle E,Moray G,harman a Is percutaneous cholecystostomy bridge to cholecystectomy or definite therapy in high-risk patients with severe acute calculous cholecystitis?. Annals of Medical Research. 2021; 28(1): 113 - 119. 10.5455/annalsmedres.2020.08.819
Vancouver	avcı t,Yabanoğlu H,Aydin H,Karagülle E,Moray G,harman a Is percutaneous cholecystostomy bridge to cholecystectomy or definite therapy in high-risk patients with severe acute calculous cholecystitis?. Annals of Medical Research. 2021; 28(1): 113 - 119. 10.5455/annalsmedres.2020.08.819
IEEE	avcı t,Yabanoğlu H,Aydin H,Karagülle E,Moray G,harman a "Is percutaneous cholecystostomy bridge to cholecystectomy or definite therapy in high-risk patients with severe acute calculous cholecystitis?." Annals of Medical Research, 28, ss.113 - 119, 2021. 10.5455/annalsmedres.2020.08.819
ISNAD	avcı, tevfik vd. "Is percutaneous cholecystostomy bridge to cholecystectomy or definite therapy in high-risk patients with severe acute calculous cholecystitis?". Annals of Medical Research 28/1 (2021), 113-119. https://doi.org/10.5455/annalsmedres.2020.08.819